|Bid||83.05 x 900|
|Ask||83.99 x 1100|
|Day's Range||82.70 - 84.65|
|52 Week Range||57.17 - 89.74|
|Beta (5Y Monthly)||0.43|
|PE Ratio (TTM)||31.82|
|Earnings Date||Feb 02, 2023|
|Forward Dividend & Yield||2.92 (3.50%)|
|Ex-Dividend Date||Dec 14, 2022|
|1y Target Est||86.92|
Let's look at the four biotech/pharma companies slated to release quarterly results on Feb 2.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
FOSTER CITY, Calif., February 01, 2023--Gilead awards $7.6 million in grants to 24 U.S.-based organizations through the newly created Toward Health Equity Oncology Grant(TM).